|
|||||
|
|
Nimotuzumab and radiotherapy for treatment of newly diagnosed diffuse intrinsic pontine glioma (DIPG): a phase III clinical study |
|
| Authors: | Fleischhack G. Massimino M. Warmuth-Metz M. Khuhlaeva E. Janssen G. Graf N. Rutkowski S. Beilken A. Schmid I. Biassoni V. Gorelishev S. K. Kramm C. Reinhard H. Schlegel P. G. Kortmann R.-D. Reuter D. Bach F. Iznaga-Escobar N. E. Bode U. |
| Affiliation: | 1.Department of Neurology, Yale School of Medicine, New Haven, USA ;2.Department of Pathology, Yale School of Medicine, New Haven, USA ;3.Department of Radiology and Biomedical Imaging, Yale School of Medicine, New Haven, USA ;4.Department of Neurosurgery, Yale School of Medicine, New Haven, USA ;5.Departments of Neurology and Neurosurgery, Section of Neuro-Oncology, Yale School of Medicine, Yale Cancer Center, 333 Cedar Street, New Haven, CT, 06510, USA ; |
| Abstract: | Journal of Neuro-Oncology - Children with recurrent medulloblastoma have a poor prognosis. Re-irradiation is an option for some patients, but has not been well-studied in the era of molecular... |
| Keywords: | |
| 本文献已被 SpringerLink 等数据库收录！ | |